The Motley Fool, founded in 1993 by brothers David and Tom Gardner, is a multimedia financial services company dedicated to empowering individual investors with accessible, actionable advice. Headquartered in Alexandria, Virginia, the company offers a range of products, including stock recommendations, investment research, and personal finance guidance, through its popular website, newsletters, podcasts, and premium subscription services.
Nvidia Stock: Buy, Sell, or Hold? Nvidia's revenue growth is accelerating, and margins are expanding. But does the stock's valuation leave enough room for the risks?
Could Investing $10,000 in Costco Wholesale Make You Richer? A company selling $1.50 hot dogs has made investors very wealthy over the past few decades.
Dividend Stability or Growth Exposure? SCHD and FDVV The Schwab U.S. Dividend Equity ETF (SCHD) emphasizes durable dividend payers with strong financial health, while the Fidelity High Dividend ETF (FDVV) mixes dividend income with exposure to large growth companies. Understanding how these strategies differ can help investors decide whether their dividend allocation should prioritize income stability or participation in market-leading stocks.
2 Top Tech Stocks to Buy in March These companies are built for long-term sustained success.
Why Micron Stock Is Gaining Today Despite sell-offs for many tech stocks, Micron's share price is moving higher today.
VGT vs. XLK: Which Broad Tech ETF Is the Better Buy Right Now? Explore how differences in holdings, fees, and sector coverage could influence your choice between these top tech ETFs.
Is USA Rare Earth Stock a Millionaire Maker? USA Rare Earth's stock has attracted significant investor attention amid U.S. efforts to secure domestic rare-earth production.
A Hedge Fund Just Trimmed $2.7 Million of NCR Voyix. Should You Care? NCR Voyix delivers technology and managed services across retail, hospitality, and financial services for enterprise clients worldwide.
2 Monster Stocks to Hold for the Next 10 Years Energy is vital to the world, and these two North American giants are reliable dividend payers.
Should You Buy the Dip on CoreWeave's Stock? CoreWeave's growth is impressive, but its stock returns have been lackluster.
Is Bio-Techne Stock a Buy, Sell, or Hold After a Wealth Manager Dumps Its Entire Stake? Bio-Techne develops specialized reagents and diagnostic solutions for global research and clinical markets in the life sciences sector.
Is Dentsply Sirona Stock a Buy After a Company Director Purchased 15,000 Shares? This global dental technology firm, with strong recurring revenues, reported a notable insider buy following a year of share price declines.
Can the Revived Jeep Cherokee Save Stellantis? It's pretty wild to think one vehicle could make such a difference for a company, but the Jeep Cherokee is hugely important. Here's what investors can expect.
HDV vs. SCHD: Which Dividend ETF Is Best? Explore how two leading dividend ETFs differ in cost, diversification, and sector focus—key factors that can shape your income strategy.
3 Under-the-Radar Artificial Intelligence (AI) Stocks With Explosive Potential These three under-the-radar companies are using AI to transform healthcare offices, physical security screening, and lending decisions.
Engineers Gate Trims Sabra Health Care REIT Stake as Investors Track Rental Income Trends Sabra Health Care REIT owns more than 400 skilled nursing and senior housing properties leased to healthcare operators across North America. Investors will be watching whether rent collections and occupancy trends can sustain the steady income and dividends that define healthcare REIT investments.
Jobs Data Just Shook the Market. Here's How Smart Investors Should Respond A surprising jobs report and rising oil prices are putting the Fed in a tough spot, and your portfolio may need to be adjusted.
Why Stock Indexes Ended This Week in the Red The S&P 500, Nasdaq, and Dow all dropped this week. Here's why rising energy stocks couldn't save them.
Top 3 Consumer Staples Dividend Stocks for Reliable Income in 2026 If you need reliable income, start by looking at companies that have proven payment histories: Dividend Kings.
The Strait of Hormuz Is Closed, and Why That's a Huge Problem for the Price of Oil and the S&P 500 The Iran-U.S. conflict is already weighing on the markets, and things could get worse if it doesn't end soon.
Why Circle Should Outperform Coinbase With two leading crypto stocks down lately, both are enticing, but Circle has something that Coinbase doesn't.
Why Adobe Stock Dropped After Earnings? And What Investors Are Missing Adobe's latest earnings reveal a deeper challenge that goes beyond one simple quarter.
Better Crypto Buy Right Now With $1,000: XRP vs. World Liberty Financial There are some superficial similarities between these two assets, but they're not in the same league as investments.
Global Business Travel Group's CTO Sold Over 100,000 Company Shares. Is the Stock a Buy or Sell? This technology-driven B2B travel platform reported significant insider selling amid a year marked by a double-digit share price decline.
3 AI Stocks Caught in the Crossfire of the Iran War, and What Smart Investors Should Do in 2026 Artificial intelligence (AI) stocks are playing important roles behind the scenes for the U.S. in its battles with Iran.
Why Karat Packaging Stock Soared Today Double-digit sales growth has this quiet packaging supplier on investors' radar.
The Artificial Intelligence (AI) Stock That Wall Street Says Could Rally 58% From Here Shares of Nebius have more than tripled over the past year, with the potential to deliver further upside due to the eye-popping revenue growth it can clock.
Concorde Financial Exits Howard Hughes Holdings, Developer of Large Sun Belt Communities Howard Hughes owns large land holdings in fast-growing markets such as Las Vegas, Houston, and Phoenix, where it has developed master-planned communities over many years. Investors will watch whether the company can convert housing demand into both land sales and long-term retail, office, and mixed-use development.
Should You Buy the Dip on Oklo Stock? The nuclear energy stock is down 65% from all-time highs.
Credo Tech (CRDO) Has 1 Problem. Here's Why I'm Buying Anyway. Credo Technology may look risky on the surface, but its technology advantage could make it one of the most critical infrastructure players in the AI boom.
Is Workiva Stock a Buy After Investment Firm 13D Opened a New Position Worth $4.5 Million? Workiva delivers cloud-based compliance and data integration solutions to corporations, government agencies, and educational institutions.
Want to Invest in Quantum Computing? 2 Stocks That Are Great Buys Right Now Quantum computing is an emerging growth area for artificial intelligence investors.
Better AI Stock to Buy Now: Nvidia vs. Broadcom Nvidia and Broadcom are two top AI infrastructure stocks.
Why Shares of Nio Stock Soared 21% This Week The electric vehicle maker is riding high on accelerating vehicle sales.
What Is Going on With Block Stock Right Now? The innovative financial services business saw its share price pop more than 20% after it reported Q4 2025 financials last month.
Visa vs. Mastercard: Which Stock Will Make You Richer? These two massive financial stocks have lagged the S&P 500 in the past five years.
Better Mining Stock: The Metals Company (TMC) vs. SSR Mining (SSRM) As precious metals and critical minerals come into focus, mining stocks offer investors significant upside potential.
Meet a Discount Retailer Stacking Monster Comps on Top of Monster Comps This emerging international concept just posted 34% revenue growth in its latest quarter.
Got $1,000? 3 Stocks to Buy Now While They're On Sale These players are present in the tech and consumer goods markets.
Education Stock Up 84% as One Fund Ups Stake to Nearly $6 Million Laureate Education runs a network of universities, offering degree programs in Latin America and the U.S. through campus and online formats.
What to Know About a $6 Billion Mortgage Bond ETF That Became This Fund's Largest Holding The First Trust Low Duration Opportunities ETF targets income and risk management through a portfolio focused on mortgage-related securities.
These 2 Years Could Be Especially Hard on Retirees' Budgets These two changes aren't that far off and could have a huge effect on your quality of life.
This Fund Bet $200 Million on a Biotech Stock Up 50% as Kidney Disease Drug Targets July 7 FDA Decision Vera Therapeutics develops biologic therapies for serious immunological diseases, with a pipeline targeting high-burden conditions.
Dara Khosrowshahi Just Gave Uber Investors Great News The successful CEO is addressing the mobility company's biggest risk factor.
